Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest specific 2 like 1 pseudogene 1 (GAS2L1P1) is a human pseudogene related to the GAS2L1 gene but does not encode a functional protein. Pseudogenes such as GAS2L1P1 arise from duplication or retrotransposition events but typically lack protein-coding capability due to disruptive mutations or loss of regulatory elements. There is no evidence in public biomedical literature or curated gene/protein/drug databases that GAS2L1P1 takes part in physiological processes, disease mechanisms, or serves as a therapeutic target. The functional gene, GAS2L1, belongs to the GAS2 family, which is involved in cytoskeleton regulation, but this relationship does not extend to the pseudogene[3]. Therefore, GAS2L1P1 should not be considered a therapeutic target, and its listing as a target may be the result of misannotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest specific 2 like 1 pseudogene 1 (GAS2L1P1).